Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026
17/12/2025 14:44
Dec 17 (Reuters) - CNS Pharmaceuticals Inc CNSP.O: CNS PHARMACEUTICALS INC - APPOINTS RAMI LEVIN AS CEO EFFECTIVE JAN 1, 2026 - SEC FILING CNS PHARMACEUTICALS INC - JOHN CLIMACO RESIGNS AS CEO AND BOARD MEMBER EFFECTIVE DEC 16, 2025 - SEC FILING Source text: [ID:n0001683168-25-009208] Further company coverage: CNSP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026